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Abstract: Illumina and nanopore sequencing technologies are powerful tools that can be used to
determine the bacterial composition of complex microbial communities. In this study, we compared
nasal microbiota results at genus level using both Illumina and nanopore 16S rRNA gene sequencing.
We also monitored the progression of nanopore sequencing in the accurate identification of species,
using pure, single species cultures, and evaluated the performance of the nanopore EPI2ME 16S data
analysis pipeline. Fifty-nine nasal swabs were sequenced using Illumina MiSeq and Oxford Nanopore
16S rRNA gene sequencing technologies. In addition, five pure cultures of relevant bacterial species
were sequenced with the nanopore sequencing technology. The Illumina MiSeq sequence data were
processed using bioinformatics modules present in the Mothur software package. Albacore and Guppy
base calling, a workflow in nanopore EPI2ME (Oxford Nanopore Technologies—ONT, Oxford, UK) and
an in-house developed bioinformatics script were used to analyze the nanopore data. At genus level,
similar bacterial diversity profiles were found, and five main and established genera were identified
by both platforms. However, probably due to mismatching of the nanopore sequence primers,
the nanopore sequencing platform identified Corynebacterium in much lower abundance compared
to Illumina sequencing. Further, when using default settings in the EPI2ME workflow, almost all
sequence reads that seem to belong to the bacterial genus Dolosigranulum and a considerable part to the
genus Haemophilus were only identified at family level. Nanopore sequencing of single species cultures
demonstrated at least 88% accurate identification of the species at genus and species level for 4/5 strains
tested, including improvements in accurate sequence read identification when the basecaller Guppy
and Albacore, and when flowcell versions R9.4 (Oxford Nanopore Technologies—ONT, Oxford, UK)
and R9.2 (Oxford Nanopore Technologies—ONT, Oxford, UK) were compared. In conclusion, the
current study shows that the nanopore sequencing platform is comparable with the Illumina platform
in detection bacterial genera of the nasal microbiota, but the nanopore platform does have problems
in detecting bacteria within the genus Corynebacterium. Although advances are being made, thorough
validation of the nanopore platform is still recommendable.
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1. Introduction
The use of traditional culture and established 16S rRNA gene sequencing techniques has shown
that the composition of the nasal microbiota comprises microbiota profiles, dominated by four or five
microbial genera. The microbiota composition varies in individuals with age [1], and shows large-scale
variations in the first few years of life [2]. This variation usually involves colonization with Streptococcus
pneumoniae, Haemophilus influenzae and Moraxella catarrhalis (three bacterial species often associated
with the development of upper respiratory tract infections, including otitis media in young children)
as well as Staphylococcus aureus, Dolosigranulum sp. or Corynebacterium spp. Further, the composition of
the nasal microbiota has been associated with several other diseases, including the progression of cystic
fibrosis [3], chronic rhinosinusitis [4], and progression to pneumonia after respiratory syncytial virus
upper respiratory tract infection [5]. Nasal colonization with bacterial species such as Streptococcus
pneumoniae, Haemophilus influenza, Moraxella catarrhalis, and Staphylococcus aureus may in the majority
of cases be mutualistic or commensal, though a disturbance in this symbiotic relationship could lead
to dysbiosis and disease, especially when these bacteria may also be present in the nasopharynx [6].
However, this phenomenon may not be related to microbiota profiles alone, but to a combination of
bacterial, viral and child characteristics [7].
Unfortunately, traditional culture techniques are unable to detect a wide range of the so-called
‘non-culturable’ bacteria that DNA sequencing techniques have indicated to be present within the
human nasal microbiota [8]. Also, to date, accurate species identification using 16S rRNA gene
sequencing protocols in combination with the most popular sequencing platform (Illumina sequencing)
is currently not universally possible as only short regions of bacterial 16S rRNA genes tend to be
sequenced using Illumina technology [9]. This means that the majority of microbiota publications to
date have been limited to reporting the diversity of the (nasal) microbiota at best at the genus level.
However, the accurate speciation of bacteria can be very important for clinicians as a bacterial genus
may contain several species that possess very different virulence characteristics [10]. For example,
being able to differentiate between a Staphylococcus aureus and a Staphylococcus epidermidis infection
may be significant in the treatment of sepsis or skin infections.
Nanopore sequencing (Oxford Nanopore Technologies—ONT, Oxford, UK) [11], is a ‘third
generation’ (i.e., single-molecule) sequencing technology that is able to generate long sequence
read-lengths that can span the majority of the bacterial 16S rRNA gene. Several recent comparative
studies demonstrated promising results for the nanopore technology including identification of the
microbiota composition at the species level. For example, a significantly similar bacterial composition
at genus level and the identification of more bacterial species was reported when Oxford Nanopore and
Illumina 16S rRNA gene sequencing were compared for the mouse gut microbiota [12]. In another study,
the performance of nanopore versus IonTorrent PGM® sequencing on mock and dog skin microbiota
samples indicated increased bacterial richness at high taxonomic levels (species identification) associated
with nanopore sequencing [13]. In a separate time course analysis, nanopore 16S rRNA gene sequencing
resulted in the detection of all 20 of the bacterial species present in a mock bacterial community within
minutes [14]. A drawback of nanopore sequencing is the relatively high sequencing error rate, ranging
from 5% [1] to 38.2% [15]. This further complicates accurate taxonomy at species level, particularly for
bacterial species with a high sequence similarity in the 16S RNA gene.
Although comparisons of nanopore sequencing with other sequencing systems have previously
been published, to our knowledge no comparative data were published with a specific focus on the nasal
microbiota. The nasal microbiota contains microbial species at lower microbial abundance compared
to high-biomass samples such as feces. It, however, may be a source of potential antibiotic-resistant
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pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) [16]. In this manuscript,
we compared Illumina versus nanopore sequencing at genus level using nose swab samples that
had been obtained from the European Union-funded FP7 project [17]. Initial comparative research
was performed using version R9.2 nanopore sequencing devices (flowcells), the Albacore basecaller
and earlier versions of the EPI2ME 16S sequence data analysis pipeline, which is still evolving
and being updated by ONT [18]. Therefore, subsequent to, and based on, the results of our initial
comparative analysis, we performed further analysis and investigated the potential effect of newer
ONT advancements (EPI2ME, the Guppy basecaller and flowcells R9.4) on the results of microbiota
profiling at genus and species level using pure cultures of relevant bacterial species.
2. Material and Methods
2.1. Sample Collection and Selection
Fifty-nine nose swab samples generating at least 1000 Illumina sequence reads and 3 × 103 16S
rRNA gene copies per microliter were randomly selected for nanopore 16S rRNA gene sequencing.
These samples had been previously obtained from patients with lower respiratory tract infections,
sepsis, and non-infected control patients participating in the EU FP7-funded TAILORED-treatment
study, and Illumina sequenced. They comprised nose swab samples from 10 adults and 49 children
under the age of 18. Seven negative control swabs were also sequenced, containing nasal swab
Universal Transport Medium (UTM, ESwab™, COPAN Diagnostics Inc., Brescia, Italy) only.
2.2. DNA Isolation
DNA was previously isolated from nasal swab samples using the mag mini kit (LGC Standards,
Wesel, Germany) and an adjusted protocol that included an initial bead-beating step. In short, 200 µL
of nose swab medium combined with 200 µL phenol and 150 µL Lysis buffer BL (LGC Standards,
Wesel, Germany) was added to a vial containing Lysing Matrix beads (MP Biomedicals, Eschwege,
Germany) and subjected to bead-beating using a FastPrep-24 (MP Biomedicals, Eschwege, Germany)
at 6m/s for 60 s. After centrifugation, 200 µL of the water phase (top layer) was incubated for 2 min at
room temperature with 400 µL binding buffer BL (LGC Standards, Wesel, Germany), to which 10 µL
mag particle suspension (LGC Standards, Wesel, Germany) had been added. The manufacturer’s
protocol was then followed, with the exception that the DNA was eluted by incubating for 30 min
at 55 ◦C instead of 10 min. Prior to 16S rRNA gene sequencing, the total number of 16S rRNA gene
copy numbers within each DNA extract was measured using a 16S rRNA gene quantitative PCR as
previously described [19].
2.3. Bacterial Strains
The following purely cultured bacterial strains were used in this study: Haemophilus influenzea
ATCC 10211, Moraxella catarrhalis ATCC 25240, Staphylococcus aureus ATCC 25923, Staphylococcus
epidermidis ATCC 12228, Streptococcus pneumoniae ATCC 49619, Corynebacterium diphtheria ATCC 13812,
and from our own hospital strain collection: Corynebacterium accollens, Corynebacterium amycolatum,
Corynebacterium pseudodiphtheriticum, and Corynebacterium striatum. The identity of the hospital
isolates used was confirmed by matrix-assisted laser desorption ionization-time of flight spectrometry
(MALDI-TOF MS, Bruker Daltonics).
2.4. Illumina Sequencing
The hypervariable V5 and V6 regions (276 base pairs—bp) of the 16S rRNA gene were amplified
using the 785F (5′-GGA TTA GAT ACC CBR GTA GTC-3′) and 1061R (5′-TCA CGR CAC GAG CTG
ACG AC-3′) primers [20], and dual indexing [21]. Amplicons were generated in 30 cycli using the
FastStart High Fidelity System (Roche, Woerden, The Netherlands), normalized using the SequalPrep
Normalization Plate kit (Thermo Fischer Scientific, Breda, The Netherlands) and pooled in batches of
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approximately 250 samples. Pools were purified prior to sequencing using the Agencourt AMPure XP
(Beckman Coulter Life Science, Indianapolis, IN, USA), and the amplicon size and quantity of the pools
were assessed on the LabChip GX (PerkinElmer Inc., Groningen, The Netherlands). The PhiX Control
v3 library (Illumina Inc., San Diego, CA, USA) was combined (~10%) with the pooled amplicon libraries
and each pool was sequenced on an Illumina MiSeq sequencer (MiSeq Reagent Kit v3, 2 × 300 bp).
2.5. Nanopore Sequencing
16S rRNA gene sequence libraries were prepared with the 16S Rapid Amplicon Barcoding
Kit (Oxford Nanopore Technologies—ONT, Oxford, UK, SQK-RAB201) according to the standard
procedures described by ONT. The complete 16S rRNA gene was amplified using 10 µL input DNA
purified from nasal swabs, LongAmp® Taq 2× master mix (New England Biolabs, Ipswich, MA,
USA) and the barcoded nanopore sequence primers 27F 5′-AGA GTT TGA TCM TGG CTC AG-3′
and 149R 5′-CGG TTA CCT TGT TAC GAC TT-3′. The DNA amplification was performed on a
T100 Thermal Cycler (Biorad, Lunteren, The Netherlands) using the program; 1 min denaturation
at 95 ◦C, 25 cycles (95 ◦C—20 s, 55 ◦C—30 s, 68 ◦C—2 min) and a final extension step of 5 min at
65 ◦C. The 16S rRNA gene amplicons were quantified using Quant-IT™ PicoGreen™ (Thermo Fisher
Scientific, Breda, The Netherlands), equal amounts of amplicons per sample were pooled and the
library was further processed as described by the manufacturer. Next, the library was incubated with
Library Loading Beads (Oxford Nanopore Technologies—ONT, Oxford, UK) and the mixture was
added to the MinIon/GridIon flow cell (version R9.2 or R.9.4, Oxford Nanopore Technologies—ONT,
Oxford, UK). Sequencing was performed using a MinIon or GridIon nanopore sequencer (Oxford
Nanopore Technologies—ONT, Oxford, UK) for approximately 16 h.
2.6. Data Analysis
The Illumina MiSeq sequence data were analyzed using bioinformatics modules present in the
Mothur software package [22], that we previously integrated into Galaxy (i.e., Galaxy mothur Toolset,
Gm [23]). In short, forward and reverse FASTQ-formatted sequence files were merged using the
make.contigs command. Primer sequences were trimmed and sequences that had an ambiguous base
call (N) in the sequence or with lengths smaller than 200 were removed from the analysis. Unique
sequences were then aligned against a customized reference alignment based on the SILVA reference
alignment release 123 [24,25]. The reference sequences were trimmed to only include the V5–V6
region of the 16S rRNA gene using the pcr.seqs command. Sequences that did not align to this
region were culled from further analysis and the alignments were trimmed so that the sequences fully
overlapped the same alignment coordinates. Next, sequences were further de-noised by pre-clustering
the sequences using the pre.cluster command allowing for up to two differences between sequences, and
potentially chimeric sequences were removed using Uchime, as implemented in Mothur. The remaining
sequences were classified using the classify.seqs command with the customized SILVA alignment
release 123 as reference. Finally, sequences were clustered into operational taxonomic units (OTUs) at
97% similarity using the default settings of the dist.seq and cluster commands respectively, and the
classify.otu algorithm was used to get a consensus taxonomy for each OTU.
Basecalling of nanopore signals was performed using the MinKNOW (MinION software,
version 1.6, Oxford Nanopore Technologies—ONT, Oxford, UK) embedded Albacore version 1.0
data processing pipeline or the Guppy version 3.2.10 pipeline (Oxford Nanopore Technologies—ONT,
Oxford, UK). The Barcoding workflow in the Metrichor Ltd. analysis platform EPI2ME (Oxford
Nanopore Technologies—ONT, Oxford, UK) [26] was used for the de-barcoding of the sequence
reads derived from the nose swab samples sequenced with the Oxford Nanopore platform. For the
identification of bacteria at genes and species level, fast5 or fastq files containing full length 16S rRNA
gene amplicons where uploaded to the EPI2ME desktop agent 16S workflow (versions 2.47.53720F8,
2.48.690655 or 2020.2.10, Oxford Nanopore Technologies—ONT, Oxford, UK) where each file was
classified real-time using the NCBI 16S rRNA gene blast database [27]. Blastn was run using the
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parameters max_target seqs = 3 (finds the top three hits that are statistically significant) and output
fmt = 6. The number of genera represented in the top three classifications (num_genus_taxid) was
calculated along with the genus rank (if classified at genus rank or below) per sequencing record.
These were calculated using the Python library ete2 [28], which utilizes the NCBI taxonomy. The top
scoring classification per individual record within the file was selected as the read classification along
with the accompanying num_genus_taxid and genus and species information. Coverage information
per read was calculated as number of identical matches/query length. All read classifications were then
filtered for >77% accuracy and >30% coverage, which removes spurious alignments. Results were
returned via a web report and can be downloaded as a comma-separated values (CSV) file.
Then, the results in the CSV file of the EPI2ME 16S workflow output were used for further analysis
using an in-house-generated Python script together with the Python ete2 package. This script reads the
contents of the CSV file and retrieves the species and genus names from the NCBI taxonomy IDs found
by the EPI2ME 16S workflow. Exclusion criteria for the single nanopore reads were an alignment count
accuracy <80%, quality score (QC) score <7, read length <1400 >1700 bp, and a num_genus_taxid other
than 1 or 2. These exclusion criteria apply for the initial analyses of the nasal swab samples in this study.
For the nasal swab samples that were re-basecalled with Guppy, and the purely cultured bacterial
strains that were (re-) basecalled with Guppy, the applied exclusion criteria were: alignment count
accuracy 85%, QC score <9, read length <1400 >1700 bp, and an lca score other than 0. For species
level identification, similar criteria and the highest scoring BLAST identification (top rank) was used.
The higher accuracy and QC thresholds were chosen because (re-) basecalling with Guppy or using a
R.9.4 flowcell resulted in a higher average QC score (from at least 7 to ~10) and accuracy (from ~85%
to ~90%) in the EP2ME analysis (R9.2 flowcell, Albacore basecalling versus R9.2 or R9.4 flowcell and
Guppy basecalling, respectively, data not shown). On average, ~15% of the reads were excluded after
re-basecalling with Guppy and filtering with the more stringent thresholds (data not shown).
2.7. Statistics
Rarefaction analysis was performed to determine the amount of reads needed to accurately
assess the bacteria richness in the samples (Supplementary Figure S1). Plots were generated
with QIIME (Quantitative Insights Into Microbial Ecology) version 1.9.1 (multiple_rarefactions.py,
alpha_diversity.py, collate_alpha.py, make_rarefaction_plots.py) using the Shannon diversity metric.
Based on the rarefraction analysis, samples generating >500 sequence reads were included for
bioinformatics analysis.
Taxonomy results of the data produced after Illumina and nanopore sequencing were loaded into
BioNumerics software version 7.6 (Applied Math, Sint-Martens-Latem, Belgium) and a phylogenetic
tree was generated based on the relative abundance proportions of the genera (normalized to 100%),
the Pearson’s correlation coefficient and the UPGMA algorithm. Microbiota profiles generated after
Illumina or nanopore sequencing were visualized using Microsoft Excel 2010, and ordered based on
the sample order in the phylogenetic tree. Alpha-diversity at the genus level was assessed using two
metrics: the number of observed genera present with an abundance of at least 1%, and the inverse
Simpson index (ISI). Bland-Altman plots were made to explore the comparability of the microbiota
profiles generated by Illumina and nanopore sequencing for the six most prevalent genera. These
plots show the difference in measured percentages between the two methods versus the mean of the
measured percentages.
2.8. Sequence Data Availability
The Illumina and nanopore sequence datasets of the nose swab samples, generated and analyzed
in the current study, are available in the European Nucleotide Archive (ENA) under accession number
PRJEB28612 [29].
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3. Results
3.1. Sample Population
Fifty-one nose swab samples from patients with a respiratory tract infection or sepsis and eight
control patients (no infection) were included in the study (Table 1). Most patients were children
under the age of 5 years (37/59, 63%). It should be noted that the current analysis was designed to
investigate differences between Illumina and nanopore sequencing of nasal microbiota profiles and
not to determine possible differences between infection versus no-infection or children versus adult
patient populations.
3.2. General Sequencing Results
An average of 131,024 raw reads were generated per sample using the Illumina MiSeq platform,
with a mean of 91% of raw reads being classified into a mean of 4.4 genera, which were present with an
abundance of ≥1% per sample (Table 1). Using nanopore sequencing, an average of 21,907 raw reads
were obtained per sample and a mean of 78% of the raw reads were classified into a mean of 4.5 genera,
which were present with an abundance of ≥1% per sample (Table 1). The Illumina platform resulted in
a significantly higher ISI compared to nanopore; 2.7 vs. 2.2, p < 0.0001, paired T. test (Table 1).
For the data generated using nanopore sequencing, 2/59 (3.4%) of the samples were below the
cut-off of 500 reads. These samples were excluded from further analysis. Low read numbers ranging
from 1–3408 reads for the Illumina platform and 0–56 reads for nanopore were detected in negative
control samples (n = 7).
3.3. Illumina versus Nanopore Sequencing
Phylogenetic clustering of the taxonomy results (normalized to 100%) generated after Illumina
sequencing provided five microbial clades (I–V, Figure 1a). Clade I was dominated by Moraxella spp.;
II had a mixture of Moraxella spp., Dolosigranulum sp. and Corynebacterium spp.; III Dolosigranulum sp.
and Corynebacterium spp.; IV Haemophilus spp.; and V Staphylococcus spp. (Figure 1a). When using
the Illumina platform, Corynebacterium spp., Moraxella spp., Dolosigranulum sp., and Streptococcus spp.
were most prevalent, and 1% or more of these genera could be detected in 46, 44, 43, and 32 of the
57 samples analyzed, respectively.
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Table 1. Nose swab samples of individuals and negative controls that were sequenced using and Illumina and nanopore 16S rRNA gene sequencing technologies.
(a) = a maximum of 5000 raw Illumina sequence reads were analyzed for the classification of genera. (b) = samples with read numbers below the 500 read cut-off.
NA = not applicable.
Sample Information Illumina Technology Nanopore Technology
Sample Infection Age(Years) 16S Copies
Raw
Reads
Percentage Reads
Classified (%) (a)
Genera
Identified
≥1%
Genera
(ISI)
Raw
Reads
Percentage
Reads
Classified (%)
Genera
Identified
≥1%
Genera
(ISI)
1 yes 3.50 5 × 105 133,880 92 5 4.2 34,944 77 5 3.0
2 yes 0.92 1 × 105 186,250 95 5 1.9 15,254 79 3 2.2
3 yes 2.00 3 × 105 1661 94 5 4.1 39,474 77 4 2.9
4 yes 1.50 3 × 105 154,877 96 7 4.6 36,608 76 6 2.3
5 yes 9.00 3 × 105 114,702 97 5 3.5 5107 59 4 2.7
6 yes 2.00 3 × 105 22,805 97 5 2.7 31,642 52 4 1.7
7 yes 5.00 2 × 105 1940 88 8 3.8 2246 57 6 3.1
8 yes 4.00 3 × 105 24,214 100 4 1.2 10,174 62 3 1.2
9 yes 1.67 4 × 105 104,134 93 9 2.5 21,462 68 6 2.6
10 yes 8.00 2 × 105 186,945 96 3 2.5 923 68 2 1.6
11 yes 11.00 2 × 105 120,867 95 3 3.0 27,569 78 3 1.6
12 yes 0.42 4 × 105 25,743 98 3 3.0 5127 66 3 2.2
13 yes 15.00 4 × 105 261,123 95 4 2.7 12,572 66 5 2.0
14 yes 2.17 1 × 105 6246 97 4 3.0 20,441 89 3 2.7
15 yes 3.80 3 × 105 68,095 91 3 2.3 27,077 90 4 2.5
16 yes 2.40 1 × 105 119,295 84 7 2.9 2978 85 6 2.6
17 yes 0.80 2 × 105 74,902 96 3 1.5 4408 91 2 1.1
18 yes 61.00 3 × 103 77,851 86 6 3.4 2141 82 8 4.1
19 yes 0.90 3 × 105 74,730 85 4 2.3 20,584 82 6 1.6
20 yes 0.80 3 × 105 113,078 93 3 2.4 10,974 91 3 1.9
21 yes 78.00 2 × 105 131,837 90 2 1.7 21,449 93 1 1.0
22 yes 1.70 3 × 105 162,890 85 4 2.4 23,530 92 5 1.8
23 yes 2.30 2 × 105 83,596 92 8 4.4 15,748 88 7 3.2
24 yes 73.00 2 × 105 83,947 84 4 2.0 3181 88 5 3.3
25 yes 2.60 5 × 105 28,221 92 3 3.0 15,453 50 3 3.1
26 yes 65.00 3 × 105 77,012 82 7 4.5 31,461 85 6 2.8
27 yes 0.80 1 × 105 58,962 85 3 2.5 23,652 90 3 1.5
28 yes 3.00 5 × 105 57,600 86 6 3.7 22,991 84 7 3.4
29 yes 57.00 2 × 105 129,131 94 2 1.5 48,167 90 1 1.1
30 yes 0.40 6 × 105 180,796 88 3 2.9 3997 65 4 2.3
31 yes 0.90 4 × 105 547,695 98 4 2.7 15,626 80 7 1.7
32 yes 23.00 8 × 105 750,669 97 3 1.8 6653 67 2 1.6
33 yes 3.40 1 × 105 924,890 98 7 3.3 25,148 74 7 2.1
34 yes 4.10 1 × 106 31,896 94 5 4.0 15,979 49 4 2.7
35 yes 14.00 3 × 105 79,970 90 3 2.1 40,551 88 3 1.4
36 yes 0.10 3 × 105 113,047 88 3 1.7 50 76 NA NA
37 (b) yes 0.40 3 × 105 59,397 88 4 2.9 51,254 63 11 3.6
38 yes 0.30 6 × 105 7421 99 3 1.4 41,757 89 2 1.4
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Table 1. Cont.
Sample Information Illumina Technology Nanopore Technology
Sample Infection Age(Years) 16S Copies
Raw
Reads
Percentage Reads
Classified (%) (a)
Genera
Identified
≥1%
Genera
(ISI)
Raw
Reads
Percentage
Reads
Classified (%)
Genera
Identified
≥1%
Genera
(ISI)
39 yes 1.10 3 × 105 121,819 86 3 2.6 6340 86 6 1.9
40 yes 0.20 2 × 105 83,457 83 4 2.4 59,923 82 6 1.9
41 yes 4.20 4 × 105 92,006 87 4 2.9 17,785 90 4 2.3
42 yes 0.10 1 × 105 36,248 90 4 2.0 45,047 92 3 1.9
43 yes 0.10 2 × 105 55,585 92 5 2.3 47,084 92 3 1.4
44 yes 0.40 3 × 105 101,465 87 5 2.7 5288 80 6 1.6
45 yes 1.70 7 × 105 92,476 89 3 1.9 49,104 55 2 1.1
46 yes 0.50 3 × 105 72,068 88 4 2.1 50,486 80 6 1.5
47 yes 0.10 5 × 105 90,128 80 6 4.0 107,161 91 6 3.2
48 (b) yes 67.00 2 × 105 51,826 94 5 1.3 8 75 NA NA
49 yes 0.30 9 × 105 1148 82 8 4.3 14,673 66 3 1.5
50 yes 3.30 5 × 106 39,030 83 3 2.6 12,239 66 3 2.0
51 yes 56.00 5 × 106 2191 85 7 3.3 17,248 64 7 2.4
52 no 28.00 3 × 105 193,859 96 2 1.2 6,789 91 1 1.0
53 no 62.00 2 × 105 262,184 89 3 2.3 18,680 88 2 1.8
54 no 8.10 2 × 105 308,123 83 5 2.8 13,741 89 4 2.3
55 no 7.20 3 × 105 203,242 100 6 3.4 15,490 84 6 4.3
56 no 14.90 1 × 105 235,820 92 3 1.4 18,318 88 8 5.0
57 no 5.40 9 × 105 90,422 86 3 2.8 11,207 87 4 2.2
58 no 7.10 6 × 105 103,176 87 5 2.9 19,604 73 7 2.7
59 no 6.40 1 × 105 111,844 93 4 1.6 17,971 88 3 1.1
Average NA 12.5 8× 105 131,024 91 4.4 2.7 21,907 78 4.5 2.2
Control
C-1 NA NA <1 × 102 6 0 0 NA 7 57 4 NA
C-2 NA NA <1 × 102 1 0 0 0 42 74 8 NA
C-3 NA NA <1 × 102 1 0 0 0 33 42 9 NA
C-4 NA NA <1 × 102 3 0 0 0 35 51 11 NA
C-5 NA NA <1 × 102 2 0 0 0 15 67 3 NA
C-6 NA NA 2 × 102 2440 98 4 4 56 91 6 NA
C-7 NA NA 3 × 102 3408 94 18 18 0 0 0 NA
Genes 2020, 11, 1105 9 of 17
1 
 
 
Figure 1. Nasal microbiota profiles generated using nanopore and Illumina 16S rRNA gene sequencing.
DNA was isolated from 57 nose swab samples, and 16S rRNA gene sequencing was performed using
both Illumina (a) and nanopore (b) technologies. Each bar in the graph represents a nasal microbiota
profile from a single individual. The dashed lines in (b) represent genera that, by default, were reported
as unclassified at genus level in the EPI2ME report but were identified when next to reads with a top
three blast hit with one genera (num_genus_taxid is 1); reads with a top three blast hit with two genera
(num_genus_taxid is 2) were also included. A phylogenetic tree was generated by Pearson/UPGMA
clustering of bacterial genera in microbiota profiles, as determined using Illumina sequencing. To
compare between the two techniques, the sample order of the samples that were sequenced with the
Oxford Nanopore platform was matched to the sample order of the samples that were sequenced with
the Illumina platform, and the percentage of agreement was calculated for each nose swab sample (c).
The horizontal black line in (c) indicates the mean percentage of agreement.
In general, a similar microbiota composition was observed when the genus taxonomy results
derived from the two sequencing methods, Illumina and nanopore, were aligned and compared
(Figure 1a,b). However, initially, in the nanopore sequenced samples, Dolosigranulum sp. was classified
in very low abundance (none of that samples had >1%) in the EPI2ME output. By default, the EPI2ME
report (EPI2ME version 2.47.537208 and 2.48.690655, Oxford Nanopore Technologies—ONT, Oxford,
UK, used May–September 2017) only showed sequence reads for which the num_genus_taxid is 1.
The num_genus_taxid represents the total number of different genera out of the top three BLAST
classification results. When the num_genus_taxid is 2 or 3, two or three genera are identified in the top
3, respectively, the read is not classified at genus level but at family level (Carnobacteriaceae for the genus
Dolosigranulum), in the EPI2ME report. When we looked at the EPI2ME CSV output file, we noticed
that most reads (>95%) with a Dolosigranulum genus taxID had a num_genus_taxid of 2. When we
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added the reads with a num_genus_taxid of 2 to our results (for each genus, dashed lines in Figure 1b),
the presence and abundance of Dolosigranulum sp. and also Haemophilus spp. and Ornithobacterium
spp. in the nanopore versus the Illumina dataset appeared much more similar (Figure 1a,b).
For nanopore: Moraxella spp., Dolosigranulum sp. and Haemophilus spp. were most prevalent and
could be detected with an abundance of at least 1% in 42, 38 and 32 out of 57 samples respectively.
Overall, Moraxella spp. (33%) were most abundant, followed by Dolosigranulum sp. (18%) and
Haemophilus spp. (18%). To compare the two sequencing platforms, the sum of the percentage of
matching genera (sum of agreement) was calculated for each sample (Figure 1c). The highest sum of
agreement was 96.9%, the lowest 31.4%, and the median was 69.1%.
To assess the agreement per sample for the six main genera, Bland-Altman plots were generated.
With mean differences between 0.9 and −6.0, the detection of Dolosigranulum sp., Moraxella spp.,
Haemophilus spp., Staphylococcus spp., and Streptococcus spp. showed good agreement between the two
technologies used (Figure 2). However, Corynebacterium spp. were detected far more frequently using
Illumina sequencing compared to nanopore sequencing (mean difference = 17.1).
To further assess the variability between the Illumina and nanopore sequencing platforms,
principal coordinate analysis and PERMANOVA statistics were performed (Supplementary Figure S2)
on the microbiota profiles shown in Figure 1a,b. The platforms only contributed 5.6% to the variations
in taxonomy (Illumine versus nanopore), indicating that the platforms perform comparably.
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Figure 2. Bland–Altman plots of six main genera present in the nasal microbiota. Bland–Altman
plots were generated for the six main genera: (a) Corynebacterium, (b) Dolosigranulum, (c) Haemophilus,
(d) Moraxella, (e) Staphylococcus, and (f) Streptococcus. For each genus, the mean difference between the
two sequence methods (Illumina versus nanopore) and the limits of agreement (95% reference interval)
were calculated and shown (g).
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In 2/7 and 6/7 (Illumina and nanopore, respectively) of the negative control samples, bacterial
genera were identified (Table 1). Mostly, these genera, which included Escherichia-Shigella, Delphia and
Pseudomonas (data not shown), were uncommon in nasal swabs. An exception was negative control
C-6 in which 63% of the classified reads, 1500 reads in total, obtained through Illumina sequencing,
were identified as Corynebacterium spp. In comparison, no reads were generated from the negative
control C-6 when using nanopore sequencing.
Compared to the nose swab samples, the number of reads in the negative control samples was
maximum 2.7% of the average number or raw reads of 57 samples tested and, therefore, may not have
influenced the results obtained from the nasal swabs.
3.4. Prevalence of Corynebacterium spp.
A striking difference was the significantly lower prevalence and abundance of Corynebacterium
spp. in the nanopore sequenced samples compared to the samples sequenced by Illumina technology
(prevalence based on an abundance of at least 1% per sample: 22/57, 39% vs. 46/57, 81%, p < 0.001,
Chi squared test; total abundance in the combined nose swab samples: 2.2% vs 19.1%, p < 0.001,
t-test). There was no obvious explanation for this low prevalence in the EPI2ME CSV files. When
we checked whether the ONT 16S rRNA gene primes had a good match with the 16S rRNA gene of
Corynebacterium spp., using the 16S rRNA gene NCBI database, we found that this was not always
the case. Corynebacterium spp. that are common residents in the human nose include C. accolens,
C. amycolatum, C. aurimucosum, C. propinquum, C. pseudodiphtheriticum, and C. tuberculostearicum [30,31].
Of these species, both the forward and the reverse primer were not compatible with the 16S rRNA
gene of C. amycolatum, and there was only an eight basepair stretch (bp 2–9) of the forward primer
that annealed to 16S rRNA gene of C. propinquum. Thus, the 16S rRNA gene will not be amplified
during the PCR using the ONT 16S rRNA gene primers for the Corynebacterium species: C. amycolatum
and C. propinquum. Furthermore, the first four bp (5′ end) of the reversed primer could not anneal
to the 16S rRNA gene of C. pseudodiphtheriticum and C. tuberculostearicum. To assess how well the
ONT 16S rRNA primers performed in amplifying the 16S rRNA gene, a PCR was done using DNA
isolated from pure cultures of five Corynebacterium species that we had available in our hospital
strain collection (C. accolens, C. amycolatum, C. diphtheria, C. pseudodiphtheriticum and C. striatum) and
four species commonly present in the nasal microbiota (M. catarrhalis. H. influenzae, S. aureus, and
S. pneumoniae). In agreement with the observed underrepresentation of Corynebacterium species in the
samples sequenced with the Oxford Nanopore technology, we found that the 16S rRNA gene of the
Corynebacterium species was poorly amplified (Figure 3).Genes 2020, 11, x FOR PEER REVIEW 11 of 16 
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equal amounts of template DNA, with the exception that 30 PCR cycli instead of 25 cycli were used.
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3.5. Re-Basecalling and Analysis of the Nose Swab Samples
To determine whether upgrades in the basecaller and the 16S EPI2ME 16S pipeline improved the
detection of genera with an assigned num_genus_taxid of 2, we re-basecalled and re-analyzed the raw
reads of all nose swab samples sequenced with the Oxford Nanopore technology. For this, the most
recent version of the Guppy basecaller (version 3.2.10, Oxford Nanopore Technologies—ONT, Oxford,
UK) and the most recent version of EPI2ME (version 2020.2.10, used April 2020, Oxford Nanopore
Technologies—ONT, Oxford, UK) were used.
Instead of the num_genus_taxid, newer versions of the EPI2ME 16S pipeline assign a lowest
common ancestor (lca) score of 0 or 1 to the reads in the CSV file. Reads with an lca score of 0 in the
newer EPI2ME version are similar to reads with a num_genus_taxid of 1 in the older version, and,
by default, are considered to be accurate.
Re-basecalling slightly improved the identification of Dolosigranulum sp. (Supplementary
Figure S3). However, still 81% of the reads had an lca score of 1 and were only identified at family level
as Carnobacteriaceae. No improvement was observed for the identification of Haemophilus spp., of which
28% was identified at family level as Pasteurellaceae compared 30% in the initial analysis. Based on the
highest scoring BLAST identification (top rank), sequence reads that were identified as Carnobacteriaceae
and Pasteurellaceae did belong to the genera Dolosigranulum and Haemophilus, respectively.
3.6. Genus and Species Level Taxonomy on Pure Cultured Single Species Bacteria Using Nanopore Sequencing
To further evaluate how accurately nanopore sequencing of the nasal microbiota performed
at genus, and also species level, we sequenced five pure culture bacterial ATCC strains that reflect
species that are common to the nasal microbiota. We again followed the development of nanopore
data analysis in time and sequenced the ATCC strains twice using flowcell versions R9.2 and R9.4.
At genus level, 93.1–99.5% or the sequence reads were accurately identified for 4/5 single species using
a R9.2 flowcell and Albacore basecalling. Re-basecalling of the same sequence reads, using Guppy,
showed an improvement to 97.0–99.7% accurate identification (Figure 4a). As already observed during
sequencing of the nasal microbiota, poor genus identification was found for H. influenzae (55.1%, R9.2
flowcell, Albacore, Figure 4a). However, upon re-basecalling using Guppy or re-sequencing using a
more recent R9.4 flowcell together with Guppy basecalling, accurate identification of H. influenzae at
genus level significantly improved to 89.6% in both cases.Genes 2020, 11, x FOR PEER REVIEW 12 of 16 
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Figure 4. Genus and species level identification on pure culture species. Pure cultures of bacterial ATCC
strains were sequenced using an R9.2 or R9.4 nanopore flowcell and Albacore or Guppy basecalling.
Taxonomic assignment was performed at genus (a) and species (b) level using the EPI2ME 16S pipeline
and the following thresholds: read length ≥1400 bp ≤ 1700 bp, num_genus_taxid is 1 or lca is 0 and
accuracy ≥80%, QC ≥ 7 when albacore basecalling was used, or accuracy ≥85%, QC score ≥9 when
Guppy basecalling was used. Similar criteria and the highest scoring BLAST identification (top rank)
was used for species level identification. A is Albacore; G is Guppy basecalling.
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At species level, a similar trend of improvement was observed upon re-basecalling sequence
reads, generated with a R9.2 flowcell, using Guppy, or using a R9.4 flowcell and Guppy basecalling.
An exception was S. epidemidis, that, un-expectantly, showed poorer identification with the R9.4-
compared to the R9.2 flowcell, with 58.9% of the sequence reads being mis-identified as S. saccharolyticus
(Figure 4b).
4. Discussion
In this study, we compared and evaluated two 16S ribosomal gene sequencing strategies based on
Illumina and nanopore technologies by analyzing the nasal microbiota composition of 59 human nose
swab samples. In general, both sequencing techniques performed comparably at genus level except for
the detection of Corynebacterium spp., a main and established genus in the nasal microbiota that was
poorly detected by the Oxford Nanopore platform. New releases of a basecaller and of the nanopore
flowcell led to improved genus and species identification but not for all species tested.
Upon comparing Illumina versus nanopore sequencing of the nasal microbiota samples tested,
a comparable average diversity of 4.4 and 4.5 bacterial genera (Illumina versus nanopore) was detected
per sample. The ISI—a measure of diversity that takes the number as well as the relative abundance of
species in an environment into account—indicated greater bacterial genus diversity when Illumina
sequencing was compared to nanopore, on average 2.7 versus 2.2 respectively. These numbers are lower
than a previously published ISI of 4.1 for the nasal microbiota [30]. This difference may have been the
result of the fact that we calculated our values based on genera instead of using operational taxonomic
units (OTUs), which are more diverse and normally used for Illumina sequencing. The relative young
age of the individuals sampled in the current study and the fact that many were sampled during active
infection may also have resulted in our relatively low ISI values [32].
The most dominant genera detected by the Illumina platform were: Corynebacterium,
Dolosigranulum, Haemophilus, Moraxella, Staphylococcus, and Streptococcus. Previous culture- and
next generation sequence approaches have revealed that these are well established genera in the nasal
microbiota [31].
Initially, most of the nanopore sequenced reads derived from bacteria with the genus Dolosigranulum
were identified at family level only i.e., Carnobacteriaceae, which appeared to be due to fixed cut-off
restrictions in the output of the Oxford Nanopore Technologies EPI2ME 16S workflow.
In the EPI2ME 16S workflow, basecalled nanopore sequence reads are blasted against the NCBI
16S rRNA gene database. Although it is possible that certain species are not represented in the NCBI
database, this was not the case for Dolosigranulum sp. as 16S rRNA gene sequences of at least two
strains are present (taxid 29394 and 883103). However, exactly because there were only two 16S rRNA
gene sequences of Dolosigranulum sp. present in the NCBI database, the condition of a top three
blast hit with similar genera (num_genus_taxid is 1, or lca is 0), which is a requirement for reads
to be classified using the EPI2ME 16S workflow, cannot be met. Thus, the limited number of two
Dolosigranulum 16S rRNA genes in the NCBI 16S rRNA gene database is probably why the EPI2ME
workflow failed to identify this genus. Besides Dolosigranulum sp., the bacterial genera Haemophilus
and Ornithobacterium were also identified more abundantly when read with a top three blast hit with
two similar genera (num_genus_taxid is 2) together with reads with a top three blast hit with three
similar genera (num_genus_taxid is 1) were included in the analysis. It did not become clear to us why
this was the case.
When taking into account the inclusion of sequence reads with a num_genus_ taxid of 1 or 2,
comparison of the two sequencing platforms resulted in a median sum of agreement of 69.1%, with
the main genera Dolosigranulum, Moraxella, Haemophilus, Staphylococcus, and Streptococcus showing
good agreement. Corynebacterium, however, was severely underrepresented in the taxonomy data
generated after analysis of the nanopore sequencing results, even when reads with a num_genus_taxid
other than 1 were included. Blast analysis established that two Corynebacterium species, C. amycolatum
and C. propinquum, known to be habitants of the nasal microbiota [31], could not be detected due to
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potential incompatibility of the nanopore 16S rRNA gene sequence primers. In agreement with this
analysis, we observed that the 16S rRNA gene of several pure culture Corynebacterium spp. could not
be amplified using the nanopore 16S primes. Incomplete annealing at the first four 5′ base pairs of
the nanopore reverse primers, applicable for C. pseudodiphtheriticum and C. tuberculostearicum, may
additionally have resulted in a low prevalence of Corynebacterium species. However, the first four 5′
base pairs of this reverse primer also did not match several other species that were detected in high
abundance (including M. catarrhalis and M. nonliquefaciens), which tends to negate the hypothesis that
poor annealing of the nanopore reverse primer led to an underrepresentation of C. pseudodiphtheriticum
and C. tuberculostearicum. Still, mismatching of the nanopore primers and poor amplification of the 16S
rRNA gene of another bacterial genus, Bifidobacterium, has been reported [33]. A PCR bias due to the
relatively high genomic GC-content may be another explanation why the genus Corynebacterium was
underrepresented in the samples sequenced using Oxford Nanopore technology [34]. With respect to
nasal microbiota profiling, our results indicate that researchers should take into account the fact that
different sequencing platforms and pipelines may generate different results. However, it is usually
(due to cost) not feasible to perform research microbiota profiling using multiple sequencing platforms.
It should also be noted that Illumina and nanopore sequencing technologies are constantly evolving and
improvements in available sequencing hardware and software platforms are constantly being made.
In this respect, we also compared taxonomic analysis performance using pure cultured bacterial
isolates and the newest ONT hardware and sequence basecalling platform (R9.4 flowcells and Guppy).
At genus level, we found that at least 93% of the reads were accurately identified for 4/5 ATCC strains
tested with a R9.2 flowcell, and an improvement for the remaining strain when we used Guppy instead
of Albacore basecalling software or a R9.4 compared to a R9.2 flowcell.
Bacterial taxonomic identification at species level can be of clinical importance, as it can help guide
antibiotic prescription in cases of infection, or potentially identify (prophylactic) species that suppress
nasal colonization of opportunistic pathogens. For example, previous studies have demonstrated that
S. epidermidis may secrete a serine protease (Esp) that is able to inhibit nasal colonization by S. aureus [35].
Further, S. mitis has been negatively associated with nasal colonization by methicillin-resistant S. aureus
(MRSA)—apparently being able to inhibit the growth of MRSA by a hydrogen peroxide-mediated
mechanism [36].
When we addressed species level identification of nanopore sequence reads, we found that 4/5
pure culture species were accurately identified when using a R9.4 flowcell and Guppy basecalling.
However, species identification of S. epidermidus was found to occur with almost 60% of reads being
mis-classified as S. saccharolyticus. This mis-classification may have been the result of a high degree
of sequence similarity between the S. epidemidis and S. saccharolyticus 16S rRNA gene. Because the
bacteria were grown under aerobic conditions in which anaerobic S. saccharolyticus does not grow,
contamination of the S. epidermidus culture with S. saccharolyticus before DNA isolation is not plausible.
5. Conclusions
In conclusion, the current study shows that microbiota profiling of the human nasal microbiota,
using nanopore sequencing platform, is comparable to Illumina sequencing at the genus level and above.
However, nanopore sequencing may not accurately identify bacteria within the genus Corynebacterium.
At the species level, it appears that advances still need to be made to improve the accuracy of taxonomic
classification by nanopore sequencing (as with other sequencing technologies). Since our initial
comparative studies began, accurate taxonomic assignment at species level using nanopore sequencing
continues to improve, with advances in reducing the relatively high error rate of nanopore sequencing,
generating obvious advantages. Such changes are to be welcomed. However, constantly evolving
hardware and software outputs complicate downstream data analysis and make the comparison of
historically published results with more recent results potentially problematic.
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